Log In
BCIQ
Print this Print this
 

BeiGene-290, BGB-290

  Manage Alerts
Collapse Summary General Information
Company BeiGene Ltd.
DescriptionPoly(ADP-ribose) polymerase-1 (PARP-1) and PARP-2 inhibitor
Molecular Target Poly(ADP-ribose) polymerase-1 (PARP-1) ; Poly(ADP-ribose) polymerase-2 (PARP-2)
Mechanism of ActionPoly(ADP-ribose) polymerase (PARP) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$227.2M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/18/2013

Undisclosed

Undisclosed

$227.2M

Get a free BioCentury trial today